Equity Capital Markets

Company · CIK 1819790

Tarsus Pharmaceuticals, Inc.

CIK1819790 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
ListedTARS (Nasdaq)
First annual or quarterly report2020-11-25

Offerings

6 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-299429
ShelfEffective
 2026-10-132026-10-131
333-299435
ShelfEffective
 2026-10-132026-10-131
333-277523
ShelfEffective
 2024-02-292025-03-135
333-275439
ShelfEffective
 2023-11-092023-11-212
333-260665
ShelfEffective
 2021-11-012023-08-026
333-249076
IPOFinal prospectus
 2020-09-252020-10-164

Filings

20
FiledFilingRegistrationAccession
2026-10-13S-3ASRShelf registered 333-2994350001193125-26-420618
2026-10-13S-3ASRShelf registered 333-2994290001193125-26-420490
2025-03-13424B5Shelf takedown 333-2775230001193125-25-053971
2025-03-12424B5Shelf takedown 333-2775230001193125-25-052954
2024-03-01424B5Shelf takedown 333-2775230001193125-24-056182
2024-02-29424B5Shelf takedown 333-2775230001193125-24-053640
2024-02-29S-3ASRShelf registered 333-2775230001193125-24-053498
2023-11-21EFFECTDeclared effective 333-2754399999999995-23-003410
2023-11-09S-3Shelf registered 333-2754390001193125-23-274520
2023-08-02424B5Shelf takedown 333-2606650001193125-23-201711
2023-07-31424B5Shelf takedown 333-2606650001193125-23-199388
2022-05-04424B5Shelf takedown 333-2606650001193125-22-139056
2022-05-02424B5Shelf takedown 333-2606650001193125-22-135344
2021-11-05EFFECTDeclared effective 333-2606659999999995-21-004231
2021-11-01S-3Shelf registered 333-2606650001193125-21-315579
2020-10-16424B4Final prospectus 333-2490760001193125-20-271157
2020-10-15EFFECTDeclared effective 333-2490769999999995-20-002862
2020-10-09S-1/AAmendment 333-2490760001193125-20-267327
2020-09-25S-1Registration filed 333-2490760001193125-20-254758
2020-08-07DRSDraft made public 377-033930000950123-20-007975

All filings of this company · CSV